— Why it moved
Why BOLT Stock Spiked and Faded Today — October 23, 2026
Bolt Biotherapeutics announced a reverse merger with Prana Therapies and a major financing deal, but the mid-morning alert delivered almost nothing before crashing into the close.
What moved BOLT stock
Bolt Biotherapeutics is a clinical-stage biotechnology firm. The company announced a reverse merger acquisition of Prana Therapies coupled with a $120 million private placement. The deal effectively hands control over, leaving legacy shareholders with just 6.9% of the combined company.
The mechanics
A tiny float of 1,621,520 shares paired with an $8.07 million market cap allowed the headline to trigger a 66.59% gap up at the session's start. Retail chasing generated 12,859,288 shares of volume through a thin order book.
BOLT by the numbers
The alert window
The alert triggered at 11:14 AM at $7.42 and was a total trap. Anyone taking it had to sit through a immediate -5.3% drawdown to $7.03 before watching a weak bounce to $7.64 at 11:22 AM. That 3.0% peak lasted eight minutes, offering a measly five total minutes above the alert price.
How BOLT's move ended
Shares trickled down for 430 minutes after the alert, closing at $6.25 for a brutal -15.8% loss from the trigger. Mass dilutive financing and massive structural ownership changes completely crushed the early momentum.
The tell: Buying a late-morning alert on a gap-up reverse merger usually means providing exit liquidity to early presession traders.